{
    "schema": 1,
    "fid": "cagrilintide",
    "type": "article",
    "object_id": 352,
    "title": "Cagrilintide: Reference Overview and Reconstitution Notes",
    "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
    "url": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide",
    "facts_url": "https://www.preppinpeppers.com/facts/cagrilintide",
    "currency": null,
    "tldr": "Cagrilintide (AM833) is a long-acting amylin analog peptide studied in metabolic research. Investigational and not regulator-approved; reconstitution notes.",
    "facts": [
        {
            "id": "cagrilintide:title",
            "category": "identity",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "title",
            "value": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:published",
            "category": "identity",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "published",
            "value": "2026-07-10",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:author",
            "category": "identity",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "author",
            "value": "Preppin' Peppers Editorial Team",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:topics",
            "category": "identity",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "topics",
            "value": "Investigational, research",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:summary",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "summary",
            "value": "Cagrilintide (AM833) is a long-acting amylin analog peptide studied in metabolic research. Investigational and not regulator-approved; reconstitution notes.",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-1",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What it is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-2",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Cagrilintide",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-3",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Cagrilintide",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-4",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What it is",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-5",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Research context and categorization",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-6",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Status",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-7",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Reconstitution notes (general)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-8",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Dilution and handling notes (compound-specific)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-9",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Handling and storage",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-10",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Related reading",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-11",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "Tools and supplies",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:section-13",
            "category": "content",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "section",
            "value": "What the research community gets wrong about cagrilintide",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide"
        },
        {
            "id": "cagrilintide:product-gansulin-metal-peptide-pen",
            "category": "products",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "references product",
            "value": "Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-metal-peptide-pen"
        },
        {
            "id": "cagrilintide:product-gansulin-3ml-cartridge",
            "category": "products",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "references product",
            "value": "Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack)",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://www.preppinpeppers.com/products/gansulin-3ml-cartridge"
        },
        {
            "id": "cagrilintide:source-pubmed-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Kruse et al., J Med Chem 2021: Development of Cagrilintide, a Long-Acting Amylin Analogue - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/34288673/"
        },
        {
            "id": "cagrilintide:source-pubchem-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "NCBI PubChem CID 171397054: Cagrilintide (C194H312N54O59S2) - pubchem.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://pubchem.ncbi.nlm.nih.gov/compound/171397054"
        },
        {
            "id": "cagrilintide:source-pmc-ncbi-nlm-nih-gov",
            "category": "source",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Carvas et al., EBioMedicine 2025: Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3 - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12270663/"
        },
        {
            "id": "cagrilintide:source-pmc-ncbi-nlm-nih-gov-2",
            "category": "source",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Dutta et al., Indian J Endocrinol Metab 2024: Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC11642503/"
        },
        {
            "id": "cagrilintide:source-pubmed-ncbi-nlm-nih-gov-2",
            "category": "source",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Davies et al., N Engl J Med 2025: Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes - pubmed.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://pubmed.ncbi.nlm.nih.gov/40544432/"
        },
        {
            "id": "cagrilintide:source-pmc-ncbi-nlm-nih-gov-3",
            "category": "source",
            "entity": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "attribute": "cites",
            "value": "Yao et al., BMJ 2024: Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis - pmc.ncbi.nlm.nih.gov",
            "source": "Lab article (https://www.preppinpeppers.com/blogs/the-lab/cagrilintide)",
            "evidence": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10823535/"
        }
    ],
    "buy": [],
    "faq": [
        {
            "q": "What is cagrilintide and how does it differ from natural amylin?",
            "a": "Cagrilintide is a synthetic, lipidated amylin analog peptide (AM833) engineered with a fatty-acid chain and stabilizing bonds that extend its half-life compared to natural amylin, making it suitable for sustained laboratory research applications."
        },
        {
            "q": "What concentration does reconstituting a 10 mg cagrilintide vial in 2 mL bacteriostatic water yield?",
            "a": "Dividing 10 mg by 2 mL gives 5 mg/mL; using 3 mL yields approximately 3.33 mg/mL. Concentration always equals mass (mg) divided by volume added (mL). A peptide calculator avoids manual arithmetic errors."
        },
        {
            "q": "Is cagrilintide listed on the WADA Prohibited List?",
            "a": "Cagrilintide is not individually named on the WADA Prohibited List, but WADA monitors appetite- and weight-regulating peptides as a class. Status may change; always verify the current WADA Prohibited List directly before relying on any secondary source."
        }
    ],
    "jsonld": [
        {
            "@context": "https://schema.org",
            "@type": "Article",
            "headline": "Cagrilintide: Reference Overview and Reconstitution Notes",
            "url": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide",
            "mainEntityOfPage": "https://www.preppinpeppers.com/blogs/the-lab/cagrilintide",
            "datePublished": "2026-07-10",
            "dateModified": "2026-10-16",
            "author": {
                "@type": "Person",
                "name": "Preppin' Peppers Editorial Team"
            },
            "publisher": {
                "@type": "Organization",
                "name": "PreppinPeppers"
            },
            "description": "Cagrilintide (AM833) is a long-acting amylin analog peptide studied in metabolic research. Investigational and not regulator-approved; reconstitution notes."
        },
        {
            "@context": "https://schema.org",
            "@type": "FAQPage",
            "url": "https://www.preppinpeppers.com/facts/cagrilintide",
            "mainEntity": [
                {
                    "@type": "Question",
                    "name": "What is cagrilintide and how does it differ from natural amylin?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Cagrilintide is a synthetic, lipidated amylin analog peptide (AM833) engineered with a fatty-acid chain and stabilizing bonds that extend its half-life compared to natural amylin, making it suitable for sustained laboratory research applications."
                    }
                },
                {
                    "@type": "Question",
                    "name": "What concentration does reconstituting a 10 mg cagrilintide vial in 2 mL bacteriostatic water yield?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Dividing 10 mg by 2 mL gives 5 mg/mL; using 3 mL yields approximately 3.33 mg/mL. Concentration always equals mass (mg) divided by volume added (mL). A peptide calculator avoids manual arithmetic errors."
                    }
                },
                {
                    "@type": "Question",
                    "name": "Is cagrilintide listed on the WADA Prohibited List?",
                    "acceptedAnswer": {
                        "@type": "Answer",
                        "text": "Cagrilintide is not individually named on the WADA Prohibited List, but WADA monitors appetite- and weight-regulating peptides as a class. Status may change; always verify the current WADA Prohibited List directly before relying on any secondary source."
                    }
                }
            ]
        }
    ],
    "dates": {
        "published": "2026-07-10",
        "modified": "2026-10-16"
    }
}